Orbit International posts Q3 2026 consolidated bookings of about $8.2 million
Bitget2026/10/08 12:45Orbit International reported consolidated Q3 2026 bookings of about $8.2 million; deliveries started, completion expected in Q1 2028. Orbit Power Group bookings topped $3.8 million; year-to-date bookings rose 24.6% vs. the prior-year period. VPX power-supply bookings increased 58% through Sept. 30, 2026, compared with the prior-year period. Orbit Electronics Group bookings were about $4.4 million, including a $1.2 million simulator order booked in August. Simulator Product Solutions year-to-date bookings rose about 16% vs. the prior-year period; deliveries for the $1.2 million order slated for Q4. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Orbit International Corporation published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610080845PRIMZONEFULLFEED9841919) on October 08, 2026, and is solely responsible for the information contained therein.
- Orbit International reported consolidated Q3 2026 bookings of about $8.2 million; deliveries started, completion expected in Q1 2028.
- Orbit Power Group bookings topped $3.8 million; year-to-date bookings rose 24.6% vs. the prior-year period.
- VPX power-supply bookings increased 58% through Sept. 30, 2026, compared with the prior-year period.
- Orbit Electronics Group bookings were about $4.4 million, including a $1.2 million simulator order booked in August.
- Simulator Product Solutions year-to-date bookings rose about 16% vs. the prior-year period; deliveries for the $1.2 million order slated for Q4.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Canaccord Genuity: Lowers Oklo's target price to $66
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.
Dental treatment company vVardis has announced the terms for its $214 million US IPO.
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss
Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.
Crypto prices
More
